# NRX Pharmaceuticals, Inc.: Form 8-K/A, filed Nov 21, 2025

- Company: [NRX Pharmaceuticals, Inc.](/companies/nrxp.md) (CIK 1719406)
- Form: 8-K/A
- Filed: 2025-11-21
- Accepted by EDGAR: Nov 21, 2025, 16:32 ET
- Period: 2025-09-08
- Accession: 0001437749-25-036005
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1719406/000143774925036005/nrxp20251118_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1719406/000143774925036005/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1719406/000143774925036005/nrxp20251118_8ka.htm

Filed Nov 21, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-036005. Last ingested by Listed: Nov 2, 2026, 08:07 ET. No prices; not investment advice.